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ABSTRACT 
The Siddha system of medicine is a traditional Indian system which evolved with the development of 
mankind and is more of an evolution rather than invention. Siddha system describes the health of an 
individual as an ideal perfect state of the physical, physiological, social, and spiritual components of a 
human being. Diabetes is a chronic disorder linked with the metabolism of carbohydrate, protein and 
fat due to absolute or relative deficiency of insulin secretion with or without varying degree of insulin 
resistance. There is sufficient number of drugs in different systems of medicine for the management of 
diabetes but the incidence of type-II diabetes is too high. In Siddha system many more traditional 
formulations are available. Most of these medicines are clinically used by Siddha physicians but have 
not been evaluated scientifically. Naaval kottai Mathira is a anti-diabetic Siddha herbal formulation 
which is prepared from the seeds of Syzygium cumini and leaves of Aristolochia bracteolata and it has 
been used for the management of Diabetes mellitus (Madhumegam). The aim of the present study is to 
evaluate the cytotoxicity and glucose uptake activity of herbal preparation NKM using L-6 cell lines. 
The results showed that the test drug did not confer any cytotoxicity and the drug NKM showed better 
glucose uptake potential. The result of glucose uptake percentage for standard drug Rosiglitazone is 
113.26±7.72 and 32.67±4.25 for Naaval Kottai Mathirai. The findings of this investigation concluded 
that the study drug NKM has anti-diabetic activity in glucose uptake assay. 
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INTRODUCTION
 Diabetes mellitus, one of the most common 
endocrine metabolic disorders caused significant 
morbidity and mortality due to microvascular 
(retinopathy, neuropathy, and nephropathy) and 
macrovascular (heart attack, stroke and peripheral 
vascular disease) complications(1). According to the fifth 
edition of the World Diabetes Atlas released by the 
International Diabetes Federation (IDF), as of 2011, the 
total adult population in the age group of 20-79 years 
stands at 4.3 billion, out of which 366 million live with 
diabetes, which is set to increase to 552 million by 2030. (2) 
 According to World Health Organization the 
diabetic population is likely to increase up to 300 
million or more by the year 2025.(3) 
 There is sufficient number of drugs in different 
systems of medicine for the management of diabetes but 
the incidence of type-II diabetes is too high. The mainstay 
of the treatment includes oral hypoglycaemic and insulin 
(4,5). They have many side effects with their long term 
usage(6,7). Herbal drugs may be preferred as alternatives or 
adjuncts’ because of their relative safety, efficacy and 
affordability. Herbal drugs are widely prescribed and used, 
in many forms, in different systems of medicine. They are 
used though we act data substantiating their usefulness 
and efficacy. 
 Skeletal muscle is a major tissue for blood glucose 
utilization and a primary target tissue for insulin action. 
Insulin decreases glucose uptake in skeletal muscle by 
increasing functional glucose transport molecules (GLUT-
4) in the plasma membrane. Glucose transport in skeletal 
muscle can also be stimulated by contractile activity(8) 
(Dachani et al., 2012). Most drugs used for treating 
diabetes causes obesity as a side effect by reducing blood 
glucose level and inducing adipogenesis. Traditional 
medicinal plants can serve as an ideal candidate in treating 
obesity and type 2 diabetes by acting on adipocytes and 
can act as a better alternative for the treatment of 
metabolic disorders(9) (Prathapan et al., 2012). L6 cell lines 
are derived from the skeletal muscle and are used in 
antidiabetic research to study cytotoxicity / uptake of 
glucose. L6 cells represent a good model for glucose 
uptake because they have been used extensively to 
elucidate the mechanisms of of glucose uptake in muscle, 
have an intact insulin signaling pathway and express the 
insulin-sensitive GLUT-4 (10) (Ammerman et al., 2008). 
 Naaval Kottai Mathirai(11) is a herbal Siddha 
preparation which has been used for diabetes 
(Madhumegam) and mentioned in classical Siddha 
literature Kannusamiyam ennum Pathartha Guna Vilakkam 
Mooligai Vakuppu. Hence the present study was aimed to 
screen the cytotoxicity of the Naaval Kottai Mathirai by 
MTT assay and to evaluate its glucose uptake using L-6 cell 
line.  
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MATERIALS AND METHODS 
Plant material and Naaval Kottai Mathirai preparation 
 The seeds of Syzygium cumini (L.) skeels 
(Figure:1) and Aristolochia bracteolata Lam. (Figure:2) 
were collected from Seeganendal village, Pudukkottai 
district, Tamilnadu and duly authenticated by Prof. P. 
Jayaraman, Director, Plant Anatomy Research Centre, 
Chennai-45. The authentication number is PARC/2016 
/3255 and 3256. The collected seeds of S.cumini were 
powdered and grounded by adding the leaf juice of A. 
bracteolata until its waxy consistency and made into 
500mgm pills (Pattani size) (Figure:3). 
Chemicals 
 3-(4,5–dimethyl thiazol–2–yl)–5–diphenyl 
tetrazolium  bromide (MTT), Fetal Bovine serum (FBS), 
Phosphate Buffered Saline (PBS), Bovine Serum Albumin 
(BSA), D- glucose, Dulbecco’s Modified Eagle’s Medium 
(DMEM), Metformin and Trypsin were obtained from 
Sigma Aldrich Co, St Louis, USA. EDTA, Antibiotics from Hi-
Media Laboratories Ltd., Mumbai. Insulin (Torrent 
Pharmaceuticals, 40IU/ml) was purchased from a drug 
store. Dimethyl Sulfoxide (DMSO), NaOH and Propanol 
from E.Merck Ltd., Mumbai, India. 
Cell lines and Culture medium 
 L-6 (Rat, Skeletal muscle) cell culture was 
procured from National Centre for Cell Sciences (NCCS), 
Pune, India. Stock cells of L-6 were cultured in DMEM 
supplemented with 10% inactivated Fetal Bovine Serum 
(FBS), penicillin (100 IU/ml), streptomycin (100 g/ml) 
and amphotericin B (5 g/ml) in an humidified 
atmosphere of 5% CO2 at 37C until confluent. The cells 
were dissociated with TPVG solution (0.2% trypsin, 0.02% 
EDTA, 0.05% glucose in PBS). The stock cultures were 
grown in 25 cm2 culture flasks and all experiments were 
carried out in 96 microtitre plates (Tarsons India Pvt. Ltd., 
Kolkata, India).  
Preparation of test solutions 
 For cytotoxicity studies, each weighed test drugs 
were separately dissolved in distilled DMSO and volume 
was made up with DMEM supplemented with 2% 
inactivated FBS to obtain a stock solution of 1 mg/ml 
concentration and sterilized by filtration. Serial two fold 
dilutions were prepared from this for carrying out 
cytotoxic studies. 
Determination of cell viability by MTT Assay 
  The monolayer cell culture was trypsinized and 
the cell count was adjusted to 1.0 x 105 cells/ml using 
DMEM containing 10% FBS. To each well of the 96 well 
microtitre plate, 0.1 ml of the diluted cell suspension 
(approximately 10,000 cells) was added. After 24 h, when 
a partial monolayer was formed, the supernatant was 
flicked off, washed the monolayer once with medium and 
100 µl of different test concentrations of test drugs were 
added on to the partial monolayer in microtitre plates. The 
plates were then incubated at 37o C for 3 days in 5% CO2 
atmosphere, and microscopic examination was carried out 
and observations were noted every 24 h interval. After 72 
h, the drug solutions in the wells were discarded and 50 µl 
of MTT in PBS was added to each well. The plates were 
gently shaken and incubated for 3 h at 37o C in 5% CO2 
atmosphere. The supernatant was removed and 100 µl of 
propanol was added and the plates were gently shaken to 
solubilize the formed formazan. The absorbance was 
measured using a micro plate reader at a wavelength of 
540 nm. The percentage growth inhibition was calculated 
using the following formula and concentration of test drug 
needed to inhibit cell growth by 50% (CTC50) values is 
generated from the dose-response curves for each cell line 
(12) (Francis and Rita, 1986).  
   Mean OD of individual test group  
% Growth Inhibition = 100 − ---------------------------------------------- X100 
   Mean OD of control group 
In vitro glucose uptake assay 
 Glucose uptake activity of test drug was 
determined in differentiated L6 cells. In brief, the 24 hr cell 
cultures with 70-80% confluency in 40mm petri plates 
were allowed to differentiate by maintaining in DMEM 
with 2% FBS for 4-6 days. The extent of differentiation was 
established by observing multinucleation of cells. The 
differentiated cells were serum starved over night and at 
the time of experiment cells were washed with HEPES 
buffered Krebs Ringer Phosphate solution (KRP buffer) 
once and incubated with KRP buffer with 0.1% BSA for 
30min at 37 °C. Cells were treated with different non-toxic 
concentrations of test and standard drugs for 30 min along 
with negative controls at 37°C. D-glucose solution was 
added simultaneously to each well and incubated at 370C 
for 30 min. After incubation, the uptake of the glucose was 
terminated by aspiration of solutions from wells and 
washing thrice with ice-cold KRP buffer solution. Cells 
were lysed with 0.1M NaOH solution and an aliquot of cell 
lysates were used to measure the cell associated glucose. 
The glucose levels in cell lysates were measured using 
glucose assay kit. Three independent experimental values 
in duplicates were taken to determine the percentage 
enhancement of glucose uptake over controls.(13,14) 
(Takigawa-Imamura et al., 2003; Yap et al., 2007).  
RESULTS 
 The cytotoxicity of anti diabetic Siddha medicine 
Naaval Kottai Mathirai was evaluated by MTT assay. The 
CTC value of NKM is 166.45±5.4 in L 6 cell lines (Table 1. 
Fig.1). In this glucose uptake study, the drug NKM was 
found to have potent activity in enhancing the glucose 
uptake in L-6 myotubes with 18.73±6.36 and 32.67 ± 4.25 
percent uptake over controls for the drug concentration of 
50 and 100 mcg/ml respectively. The standard drug 
Rosiglitazone showed 113.26 ±7.72 percentage glucose 
uptake over control. (Table 2). 
Table 1: In - vitro cytotoxic effect of Naaval Kottai Mathirai using MTT Assay 
Sl.No Name of Test drug  Test Conc.( µg/ml) % Cytotoxicity CTC50( µg/ml) 
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Table 2: In -vitro glucose uptake activity of Naaval Kottai Mathirai in L6 cell lines 
Sl .No. Name of the Test substances Test Conc. In mcg/ml Glucose uptake percentage (%) 
1 Control - 0.74±1.19 
2 Rosiglitazone 100 113.26±7.72 




 The drug NKM has been used for the management 
of Diabetes (Madhumegam) in Siddha system of medicine. 
This present study was aimed to prove its antidiabetic 
effect by In vitro Glucose uptake in L6 cell lines method. 
The cytotoxicity of NKM was evaluated by MTT assay. The 
results showed that the test drug NKM did not show any 
cytotoxicity.  
 Skeletal muscle is a major tissue involved in 
insulin induced stimulation of glucose uptake. In the 
skeletal muscle, insulin increases glucose uptake by 
increasing functional glucose transport molecules in the 
plasma membrane. Glucose transport in skeletal muscle 
can also be stimulated by contractile activity (Atmakuri 
and Dathi, 2010). Defects in insulin stimulated skeletal 
muscle glucose uptake are common pathological states in 
noninsulin-dependent diabetes mellitus (Dachani et al., 
2012). L6 cells represent a good model for glucose uptake 
because they have been used extensively to elucidate the 
mechanisms of glucose uptake in muscle, have an intact 
insulin signaling pathway and express the insulin-sensitive 
GLUT4 (15) (Gupta et al., 2010). 
 The results of in-vitro anti diabetic effect of NKM 
by glucose uptake assay revealed the increase in 
percentage of glucose uptake in lymphocyte culture 
preparation. When compared to Rosiglitazone on 
increasing the dose of NKM, the % glucose uptake also 
increased proportionally. Rosiglitazone increases the % 
glucose uptake by skeletal muscle via glucose transporters 
and the report of the NKM also showed the increase in 
percentage of glucose uptake. So the current observations 
confirms the role of % glucose uptake and are indeed may 
be due to the activation of PPARγ by PPARγ agonist 
(insulin sensitisers) which are currently being used in the 
treatment of insulin resistance associated with type-2 
diabetis mellitus and thus influenced the peripheral 
glucose uptake. Drugs like thiazolidinediones and Insulin 
cause differentiation of pre-adipocytes into adipocytes. 
The adipocytes then stimulate glucose uptake and this aid 
in reducing the blood glucose levels. Therefore, drugs 
which exhibit glucose uptake activity would be desirable 
for patients with T2DM. The drug NKM exhibited increase 
in % glucose uptake and thus can be explored as glucose 
lowering agent to treat T2DM (16, 17). The study supports 
this hypothesis and given a lead to explore the role of NKM 
in glucose uptake. 
CONCLUSION 
 The results of the present study demonstrated 
that the drug NKM enhances the glucose uptake under in 
vitro conditions. This may due to the presence of 
phytoconstitutents in the seeds of Syzygium cumini or due 
to its effect on the receptors on the cell membrane. 
However, in vivo studies have to be carried out to 
substantiate the in vitro results by employing different in 
vivo models and clinical trials for their effective utilization 
as therapeutic agents.  
 
 
Fig. 1: In vitro cytotoxic effect of Naaval Kottai Mathirai using MTT Assay 
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Fig: 1. Syzygium cumini seed Fig: 2. Aristolochia bracteolata              Fig: 3. Naaval Kottai Mathirai 
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